Close Menu

NEW YORK – Novacyt said on Monday that its molecular test for the COVID-19 virus has received CE marking.

The company's molecular division, Primerdesign, has launched the test, which follows the launch of Novacyt's research-use-only coronavirus test on Jan. 31. Laboratories and hospitals can use the clinical test on patients without the need for validation by clinicians, according to Paris-based Novacyt.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.